Synopsis of recent research by authors named "Yong Chu"
- Yong Chu's recent research primarily focuses on the development of novel therapeutic agents targeting cancer treatment and inflammatory diseases, including selective inhibitors for MCL-1 to combat drug resistance and innovative compounds for disassembling α-synuclein fibrils relevant to Parkinson's disease.
- In addition to cancer and neurodegenerative diseases, Chu has explored advanced imaging techniques, such as correlative X-ray computed tomography and fluorescence imaging, enhancing non-invasive studies at the cellular level and the detection sensitivity of nanoscale materials.
- The research also includes the synthesis and evaluation of drugs targeting tropomyosin receptor kinases (TRKs) for precision anticancer therapies, as well as investigations into cardiac health through the modulation of signaling pathways in models of hypertension and myocardial infarction.